China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Observational Study on Post-marketing Safety of Batroxobin Injection in Patients with Occlusive Vascular Disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130808
Registration Time: 2026/08/25
Type: Observational study
Primary Sponsor: Xuanwu Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=306896
Published by HT Digital Content Services with permission from Health Daily Digest....